After months of targeting transgender youth medical care, legislators are setting their sights on restrictions against care ...

The Department of Corrections has testified before that no gender reassignment surgery is being performed for people in ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the ...

Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

From a pool of over 2 million women of reproductive age, users of most methods of hormonal contraception -- including ...

While blood clots serve an essential purpose in healing injuries, they can transform into life-threatening conditions when ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...